Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

NHS England

This public procurement record has 1 release in its history.

Award

26 Feb 2024 at 12:06

Award Notice
Summary of the contracting process

The contracting authority for the procurement process is NHS England. The tender is titled "NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024" and falls under the industry category of Pharmaceutical products. The procurement method is an Open procedure above threshold. The procurement stage is at the Award stage. The contract period starts on 1st March 2024 and ends on 31st August 2026. The tender deadline was on 22nd November 2023.

This procurement process presents significant business growth opportunities for pharmaceutical companies and suppliers in the healthcare industry. Companies specialising in pharmaceutical products, both large-scale enterprises and SMEs, are well-suited to compete for this tender. Being awarded this contract can provide extended opportunities for revenue generation and market expansion in the North of England and Midlands and East regions.

How relevant is this notice?

Notice Information

Notice Title

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

Notice Description

Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 Offer reference number: CM/PHR/22/5678 CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-9914c3d5-bf44-4fbc-a2e3-258a048efd52
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/c7b18c5b-1199-4503-86c0-f922d2e06c42
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£580,156,000 £100M-£1B
Lots Value
Not specified
Awards Value
£688,010,000 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
26 Feb 20242 years ago
Submission Deadline
22 Nov 2023Expired
Future Notice Date
Not specified
Award Date
26 Jan 20242 years ago
Contract Period
1 Mar 2024 - 31 Aug 2026 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England)
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
39
Supplier Names

Abbvie Ltd

Accord-UK Ltd

Almirall

Amgen Ltd

AstraZeneca

Aventis Pharma ltd t/a Sanofi

Bayer Plc

Biogen

CST Pharma Limited

Celltrion Healthcare United Kingdom Limited

Chugai Pharma UK Ltd

Dr.Reddy's Laboratories (UK) Limited

Eli Lilly & Company Ltd

Galapagos Biotech Ltd

Gedeon Richter UK Ltd

GlaxoSmithKline UK Limited

Ipsen

Janssen-Cilag Ltd

Kent Pharma Ltd

Merck Serono Limited

Merck Sharpe & Dohme (UK) Limited

Merz

Mylan

Napp Pharmaceuticals Ltd

Neon Healthcare Ltd

Novartis Pharmaceuticals UK Ltd

Novo Nordisk

Organon Pharmaceuticals UK Ltd

Orifarm UK

Pfizer Ltd

Pharmacosmos UK Ltd

Roche Products Ltd

Sandoz Ltd

Sobi (Swedish Orphan Biovitrum Ltd)

Sun Pharma UK Ltd

Teva UK Limited

Thornton and Ross Ltd

Vifor Pharma UK Ltd

Zentiva Pharma UK Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...